NCT01757626 2026-01-07Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk NeuroblastomaMemorial Sloan Kettering Cancer CenterPhase 1/2 Active not recruiting186 enrolled 1 FDA